Suven Life Sciences on Thursday has told that it has obtained four patents from various nations for its new chemical entities (NCEs) which could be utilized in curing different central nervous system disorders.
May 26, 2011 at 8:02 PM
Labels: Share News
|
0 comments:
Post a Comment